AGEN Agenus Inc.
Healthcare$3.32+6.75%ClosedMarket Cap: $138.3M
As of 2026-05-26
Valuation
P/E (TTM)
1322.24
PEG
13.22
P/B
-0.53
P/S
1.05
EV/EBITDA
4.52
DCF Value
$-24.04
FCF Yield
-67.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
52.1%
Operating Margin
6.6%
Net Margin
52.2%
ROE
-23.1%
ROA
34.6%
ROIC
10.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $33.7M | 98.3% | $15.1M | $39.2M | $— | — |
| Q4 null | $34.2M | 78.0% | $14.4M | $-10.6M | $— | — |
| FY null | $114.2M | 29.6% | $-20.6M | $115.0K | $— | — |
| Q3 null | $30.2M | 19.8% | $-4.5M | $63.9M | $— | — |
| Q2 null | $25.7M | -4.9% | $-16.7M | $-28.0M | $— | — |
| Q1 null | $24.1M | 10.0% | $-13.3M | $-25.3M | $— | — |
| Q4 null | $26.8M | -26.3% | $-25.9M | $-45.9M | $— | — |
| FY null | $103.5M | -50.8% | $-120.5M | $-227.2M | $— | — |
| Q3 null | $25.1M | -64.1% | $-31.5M | $-66.4M | $— | — |
| Q2 null | $23.5M | -56.9% | $-30.2M | $-53.1M | $— | — |
| Q1 null | $28.0M | 87.6% | $-32.9M | $-61.9M | $— | — |
| Q4 2023 | $83.8M | 20.1% | $-4.2M | $-46.3M | $-2.48 | — |